Asthmapolis has received FDA clearance for its asthma sensor system and associated software for web and mobile phones. The main component of the system is a small and lightweight sensor that attaches to the top of existing asthma inhalers and that determines the time and location when the inhaler was used. The sensor uses GPS for localization and communicates through Bluetooth to mobile phones which may then further upload the data to Asthmapolis’ servers.
The mobile app (available for Android and iOS) allows patients to map and track their asthma symptoms, triggers, and use of rescue and controller medications. Text message reminders may also be set for the use of controller medication. The Event Log shows details for each event, creating an asthma diary and provides the ability to review trends. The web-based patient dashboard uses maps, charts, and tables to summarize patterns of use and trends over time, but also to explore asthma in the community. The sensor data is also used to provide weekly email reports with personalized guidance and targeted education drawn from the National Asthma Education and Prevention program.
The goals of the Asthmapolis system are threefold: first providing patients with insight into their disease, secondly to improve patient-physician communication about asthma management, and thirdly the geographic tracking of inhaler use can provide information regarding environmental factors that trigger acute events. Also, the device makes a great tool for research purposes, as evidenced by the fact that Asthmapolis is currently participating in several asthma studies across the United States.
Product page: Asthmapolis Sensor and Applications…